Showing results (351-360 of 481) with videos related to

Sort By:
Pageof 49
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Blood Advances|August 15, 2025
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group reportJohn A Ligon, Lingyun Ji, Alice Dang, et al.
Nature Communications|February 13, 2016
A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiologyEric A Hungate, Sapana R Vora, Eric R Gamazon, et al.
Kidney Diseases (Basel, Switzerland)|September 14, 2020
The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two DecadesKeng Thye Woo, Choong Meng Chan, Cynthia Lim, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Molecular Cancer Research : MCR|April 26, 2020
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic LeukemiaJoanna Pierro, Jason Saliba, Sonali Narang, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Pageof 49